Breast Cancer Triple Marker

Test Name

Breast Cancer Triple Marker

Home Collection, Lab Visit

Test Code

BCTMIHC

Test Components/ Genes/ Parameters

ER,PR, Her2neu

Sample Report

Click on Icon

Test Information

TAT DETAILS

4 Days

PRE-TEST INSTRUCTIONS

Submit formalin fixed paraffin embedded Tissue Block. Ship at room temperature

CLINICAL UTILITY

This test panel uses ihc markers to detect whether your breast cancer is sensitive to hormones and has Estrogen & Progesterone receptors. This is important information for your doctor so that proper treatment can be given. If the result is positive, endocrine / hormone therapy is started. In addition, this test also detects if your cancer is Her-2 positive. In these cases, specific targeted treatment is given.

SPECIMEN STABILITY

Transport at ambient (18-25°C) temperature

METHODOLOGY

IHC

STORAGE TEMPERATURE

SPECIMEN TYPE

Surgical tissue/Tissue Block

Frequently Asked Questions

What is this Test?

Breast Cancer Triple Marker

What does it measure?

This test panel uses ihc markers (ER, PR & Her2neu) to diagnose whether your breast cancer is sensitive to hormones and has Estrogen & Progesterone receptors. This is important information for your doctor to decide the patient for Hormonal & Herceptin Therapy.

How to prepare yourself for the test?

The patient should carry the FFPE tissue or block of the effected Breast. This process is carried out by Breast Surgeon in the hospital

When should you consider this test/ when this test is recommended?

The test is recommended when patient is Diagnosed with Breast Cancer

Test Process/ how is the (test name) test performed?

Test is performed with the Immunohistochemistry technique

What are the risks of the (test name) test?

There is no risk associated with the test as biopsy will be taken by the trained surgeon in the hospital under anasthesia

How to read the test report?/ What the results may indicate?

If your tumor, or tissue sample, does not show hormone receptors, you are ER-negative, PR-negative, or negative for both. In that case, hormone therapy will most likely not be helpful to you. IHC results for HER2 are reported as 0, 1+, 2+, or 3+. A score of 0, 1+, means the tumor is HER2-negative.